ratiopharm GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Axitinib, ATC L01EK01 for the period 01092025 - 31082027 (plus extension option 1x12 months)

Germany, July 6 -- Germany based ratiopharm GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Axitinib, ATC L01EK01 for the period 01092025 - 31082027 (plus extension option 1x12 months) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....